Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Utah Medical Products stock

UTMD
US9174881089
882656

Price

60.91
Today +/-
-0.01
Today %
-0.02 %

Utah Medical Products stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Utah Medical Products stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Utah Medical Products stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Utah Medical Products stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Utah Medical Products's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Utah Medical Products Stock Price History

DateUtah Medical Products Price
1/10/202560.91 undefined
1/8/202560.92 undefined
1/7/202560.67 undefined
1/6/202560.89 undefined
1/3/202561.35 undefined
1/2/202561.35 undefined
12/31/202461.47 undefined
12/30/202460.90 undefined
12/27/202461.89 undefined
12/26/202461.58 undefined
12/24/202461.43 undefined
12/23/202461.13 undefined
12/20/202461.02 undefined
12/19/202462.08 undefined
12/18/202462.00 undefined
12/17/202462.53 undefined
12/16/202462.95 undefined

Utah Medical Products Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Utah Medical Products, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Utah Medical Products from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Utah Medical Products’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Utah Medical Products. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Utah Medical Products’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Utah Medical Products’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Utah Medical Products’s growth potential.

Utah Medical Products Revenue, EBIT and net profit per share

DateUtah Medical Products RevenueUtah Medical Products EBITUtah Medical Products Net Income
202350.22 M undefined18.44 M undefined16.64 M undefined
202252.28 M undefined20.46 M undefined16.47 M undefined
202149.05 M undefined18.9 M undefined14.79 M undefined
202042.18 M undefined13.71 M undefined10.8 M undefined
201946.9 M undefined17.63 M undefined14.73 M undefined
201842 M undefined18.7 M undefined18.56 M undefined
201741.41 M undefined19.01 M undefined8.51 M undefined
201639.3 M undefined16.19 M undefined12.13 M undefined
201540.16 M undefined15.65 M undefined11.84 M undefined
201441.28 M undefined16.2 M undefined11.38 M undefined
201340.49 M undefined14.83 M undefined11.41 M undefined
201241.55 M undefined15.2 M undefined10.17 M undefined
201137.86 M undefined11.84 M undefined7.41 M undefined
201025.12 M undefined8.92 M undefined6.01 M undefined
200925.92 M undefined9.43 M undefined6.26 M undefined
200827.78 M undefined10.39 M undefined7.21 M undefined
200728.5 M undefined10.76 M undefined7.91 M undefined
200628.75 M undefined10.84 M undefined8.17 M undefined
200527.69 M undefined9.24 M undefined7.55 M undefined
200426.49 M undefined9.26 M undefined10.22 M undefined

Utah Medical Products Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
57131723293637394238242729272627272627282827252537414041403941424642495250
-40.0085.7130.7735.2926.0924.142.785.417.69-9.52-36.8412.507.41-6.90-3.703.85--3.703.853.70--3.57-7.41-48.0010.81-2.442.50-2.44-2.505.132.449.52-8.7016.676.12-3.85
20.0028.5730.7735.2939.1341.3841.6743.2443.5945.2450.0050.0051.8551.7255.5657.6955.5655.5657.6955.5657.1453.5755.5652.0052.0059.4660.9860.0058.5460.0058.9763.4161.9063.0459.5261.2261.5460.00
12469121516171919121415151515151515161515131322252424242326262925303230
001245677884455572010787766710111111128181410141616
---100.00100.0025.0020.0016.67-14.29--50.00-25.00--40.00185.71-50.00-30.0014.29-12.50--14.29-16.6742.8610.00--9.09-33.33125.00-22.22-28.5740.0014.29-
--------------------------------------
--------------------------------------
9.6210.1511.2911.811.7211.8211.9511.6910.4510.049.458.58.277.25.985.215.264.894.684.194.043.993.883.633.643.653.713.783.773.773.773.743.753.743.673.663.643.64
--------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Utah Medical Products Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Utah Medical Products is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (k)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                       
3.84.64.76.410.69.37.213.24.511.40.60.40.40.31.516.917.52122.41619.318.56.68.914.519.323.326.44051.142.851.66175.192.87
1.51.72.33.85.26.16.66.53.83.84.143.93.63.13.33.63.53.53.73.43.12.94.53.93.63.93.73.23.63.94.74.15.15.53.34
0.10.10.10.20.2000.21.20.90.40.10.10024.90.10.90.20.20.10.10.30.20.40.70.80.9000.100000.05
1.92.83.54.24.24.243.34.85.843.233.23.53.32.93.333.23.33.43.154.44.74.94.24.55.25.46.96.26.68.89.58
00.10.10.10.10.70.50.60.70.60.60.70.60.70.90.91.10.70.60.50.40.40.40.610.80.80.80.40.40.40.40.30.50.50.43
7.39.310.714.720.320.318.323.81512.110.58.687.97.833.924.625.928.33023.226.325.216.918.624.329.732.934.549.260.954.862.273.289.9106.27
2.52.44.56.277.58.18.913.413.312.5119.88.98.999.18.28.38.68.18.18.88.88.48.38.27.41011.610.410.711.311.110.210.55
000000000000000000000000000000000000
000000000000000000000000000000000000
0.10.10.10.30.40.50.90.61.42.12.32.32.62.62.62.70.50.40.30.30.20.20.235.434.532.42824.218.317.814.830.22417.310.44.95
00000000-0.846.65.954.24.24.17.27.27.27.27.27.27.215.115.515.615.114.713.514.113.71414.214.113.413.69
02003002002000000000000000000000000000000000
2.62.74.96.77.6899.51419.421.419.217.415.715.715.816.815.815.816.115.515.516.259.358.456.351.346.341.843.538.954.949.542.53429.19
9.91215.621.427.928.327.333.32931.531.927.825.423.623.549.741.441.744.146.138.741.841.476.27780.68179.276.392.799.8109.7111.7115.7123.9135.46
                                                                       
10010010010010010010010010010010010010010000000000000000000000036
5.14.64.744.4000000000000000000.10.72.33.32.92.70.40.80.100.10.80.30.59
1.13.88.113.520.424.723.429.12423.226.42013.92016.836.735.933.336.839.535.938.938.942.949.557.364.972.981.185.6100.1110.8111115.3126138.34
000000-1000200-700-500-1,300-1,600-1,800-1,100-300200-500-700-800-1,100-1,000-1,300-2,900-9000-3,200-6,000-12,200-8,300-11,300-9,800-8,300-9,100-12,000-10,658
00000000100000000000000000000000000000
6.38.512.917.624.924.823.429.224.422.62618.812.418.315.736.436.132.836.138.734.837.937.740.750.960.664.669.669.378.188.9101102.8107114.3128.31
0.90.91.41.51.31.51.81.81.90.80.50.50.70.50.60.40.70.80.60.40.40.30.40.910.80.90.60.90.911.10.80.81.20.77
11.51.21.40.91.31.51.72.11.81.92.1221.72.92.61.71.51.51.11.11.12.21.41.51.71.81.33.13.42.432.94.43.61
01.20.50.90.50.10.10.20.10.1000009.310.70.90.900.10.21.11.41.22.41.60.81.30.80000.30.33
000000000000000000000000000000000000
0.70.70.1000000000000000.50.40.40.30.30.25.444.13.9000000000
2.64.33.23.82.72.93.43.74.12.72.42.62.72.52.312.64.33.73.43.21.81.81.99.67.87.68.9435.35.23.53.83.75.94.71
0.80.100000005.63.15.9102.55004.94.43.71.81.40.916.295.11000000000
000000.30.30.20.40.50.40.40.40.40.40.70.80.30.30.30.40.60.69.28.87.56.65.53.93.63.12.82.82.72.11.44
0.10.60.900.40.30.30.20.1000000000000000.50.400005.82.42.52.32.11.60.99
0.90.70.900.40.60.60.40.56.13.56.310.42.95.40.70.85.24.742.221.525.918.212.67.65.53.99.45.55.35.14.83.72.44
3.554.13.83.13.544.14.68.85.98.913.15.47.713.35.18.98.17.243.83.435.52620.216.59.56.914.710.78.88.98.59.67.15
9.813.51721.42828.327.433.32931.431.927.725.523.723.449.741.241.744.245.938.841.741.176.276.980.881.179.176.292.899.6109.8111.7115.5123.9135.46
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Utah Medical Products provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Utah Medical Products's financial health and stability.

Assets

Utah Medical Products's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Utah Medical Products must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Utah Medical Products after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Utah Medical Products's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (k)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1245677884455572010787766710111111128181410141616
000001111122211000000002333322267776
0000000000000000000000000-10000000000
01-1-2-10000021000-1415-2000001001006-4-41-1-20
0000000000000001,00000-1,00000000000000000000
000000000000000000000000000000000000
0132333452223332142133322433545453444
3423678111149977882758777711131215131416161720212122
00-2-2-1-1-2-2-5-1000000000000-1000-10-3-10-210000
-40-2-3-600-40-7-40000-1-15-1-204-32-2600-10-3-10-210000
-300-1-402-26-5-400000-14-1-205-24-26000000000000
000000000000000000000000000000000000
0000000005-224-72-405-1-1-10020-9-3-4-400000000
0-2,000000-6,000-8,000-3,000-13,000-5,000-1,000-11,000-11,0000-10,000-1,000-9,000-8,000-4,000-1,000-7,0000001,000000-2,000000-6,0000-2,0000
0-3000-7-8-3-130-4-9-7-7-8-6-10-4-5-6-13-3-618-11-6-8-8-6-2-4-4-10-10-5-4
000000000000000000200000000000000000
0000000000000000-1-2-2-3-4-3-6-3-3-3-3-3-3-2-4-4-4-11-3-4
-10000003-2-20000001-100-1032254431311-8891417
2.173.770.161.324.465.896.498.975.233.398.678.417.227.348.147.9527.045.168.077.117.476.765.6311.1113.311.9714.2613.5511.2315.3116.43-4.4819.2820.6520.3321.64
000000000000000000000000000000000000

Utah Medical Products stock margins

The Utah Medical Products margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Utah Medical Products. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Utah Medical Products.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Utah Medical Products's sales revenue. A higher gross margin percentage indicates that the Utah Medical Products retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Utah Medical Products's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Utah Medical Products's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Utah Medical Products's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Utah Medical Products. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Utah Medical Products's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Utah Medical Products Margin History

Utah Medical Products Gross marginUtah Medical Products Profit marginUtah Medical Products EBIT marginUtah Medical Products Profit margin
202359.81 %36.71 %33.12 %
202261.59 %39.14 %31.5 %
202163.04 %38.53 %30.15 %
202060.57 %32.5 %25.6 %
201962.84 %37.59 %31.41 %
201862.64 %44.52 %44.19 %
201763.75 %45.91 %20.55 %
201660.28 %41.2 %30.87 %
201560.23 %38.97 %29.48 %
201460.51 %39.24 %27.57 %
201359.94 %36.63 %28.18 %
201260.91 %36.58 %24.48 %
201159.17 %31.27 %19.57 %
201052.59 %35.51 %23.93 %
200953.2 %36.38 %24.15 %
200854.07 %37.4 %25.95 %
200755.4 %37.75 %27.75 %
200656.17 %37.7 %28.42 %
200556.88 %33.37 %27.27 %
200456.89 %34.96 %38.58 %

Utah Medical Products Stock Sales Revenue, EBIT, Earnings per Share

The Utah Medical Products earnings per share therefore indicates how much revenue Utah Medical Products has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Utah Medical Products earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Utah Medical Products's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Utah Medical Products’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Utah Medical Products's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Utah Medical Products Revenue, EBIT and net profit per share

DateUtah Medical Products Sales per ShareUtah Medical Products EBIT per shareUtah Medical Products Earnings per Share
202313.81 undefined5.07 undefined4.57 undefined
202214.36 undefined5.62 undefined4.52 undefined
202113.4 undefined5.16 undefined4.04 undefined
202011.49 undefined3.74 undefined2.94 undefined
201912.54 undefined4.71 undefined3.94 undefined
201811.2 undefined4.99 undefined4.95 undefined
201711.07 undefined5.08 undefined2.28 undefined
201610.42 undefined4.29 undefined3.22 undefined
201510.65 undefined4.15 undefined3.14 undefined
201410.95 undefined4.3 undefined3.02 undefined
201310.71 undefined3.92 undefined3.02 undefined
201211.2 undefined4.1 undefined2.74 undefined
201110.37 undefined3.24 undefined2.03 undefined
20106.9 undefined2.45 undefined1.65 undefined
20097.14 undefined2.6 undefined1.72 undefined
20087.16 undefined2.68 undefined1.86 undefined
20077.14 undefined2.7 undefined1.98 undefined
20067.12 undefined2.68 undefined2.02 undefined
20056.61 undefined2.21 undefined1.8 undefined
20045.66 undefined1.98 undefined2.18 undefined

Utah Medical Products business model

Utah Medical Products Inc. (UMPI) is a US-based company specializing in medical devices and products. It was founded in 1978 and has since developed an impressive range of innovative products. UMPI began with the idea of creating a better device for monitoring pregnant women and their unborn children. The first product, called "FetalGard," was a non-invasive device for quickly and accurately measuring fetal heart rates. This technology was revolutionary at the time and helped doctors and nurses make accurate diagnoses and ensure optimal obstetric care. UMPI has expanded its product range and now covers a variety of medical specialties, including gynecology/restorative, neonatology/perinatology, and blood pressure measurement. In the gynecology/restorative field, UMPI offers a wide range of products to support women's medical needs, including devices for the diagnosis and treatment of cervical cancer, obstetric instruments, and products for post-gynecological surgery recovery. The neonatology/perinatology field includes products for preterm birth prevention and support of premature infants. UMPI, for example, has developed a variety of devices for monitoring and supporting newborns, such as the "Flexxus Hydrosense," which can contribute to measuring fluid levels in newborns. In the field of blood pressure measurement, UMPI has developed a range of devices to assist doctors and medical personnel in conducting blood pressure measurements. The company is known for its highly accurate blood pressure monitors, such as the "Deltran Plus," which can be used for blood pressure measurements in adults, children, and infants. UMPI's business model focuses on the development of high-quality medical devices. The company aims to create value through these devices and help doctors and medical personnel achieve better medical outcomes. The company is proud that its products help improve patients' lives and enhance the performance of healthcare professionals. UMPI has a network of distributors and partners worldwide who contribute to making high-quality products available in the market. The company places great importance on compliance with standards and regulations and works closely with the relevant regulatory authorities. Overall, Utah Medical Products Inc. has an excellent reputation in the medical industry and is considered a reliable provider of high-quality medical devices and products. Through its innovative technology and commitment to improving medical outcomes, the company has made a significant contribution to the medical industry and will continue to play an important role in the future. Utah Medical Products is one of the most popular companies on Eulerpool.com.

Utah Medical Products SWOT Analysis

Strengths

Utah Medical Products Inc is a well-established company with a strong market presence.

The company has a diverse portfolio of medical products catering to different segments.

Utah Medical Products Inc has a reputation for producing high-quality and reliable medical devices.

The company has a dedicated and skilled workforce contributing to its success.

Weaknesses

Utah Medical Products Inc may face challenges in terms of global market expansion due to regulatory barriers.

The company's reliance on a limited number of suppliers may result in supply chain risks.

High production costs might impact the competitive pricing of Utah Medical Products Inc's devices.

Opportunities

The growing demand for medical devices presents an opportunity for Utah Medical Products Inc to expand its market share.

The company can explore new markets and partnerships to diversify its product offering.

Advancements in technology open doors for innovation and the development of new medical devices.

Threats

Intense competition within the medical device industry may pose a threat to Utah Medical Products Inc.

Evolving regulations and compliance requirements in different countries can impact the company's operations.

Changes in healthcare policies and reimbursement systems may affect the demand for medical devices.

Utah Medical Products Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Utah Medical Products Revenue by Segment

Segmente202320222021202020192018
Gynecology/Electrosurgery/Urology11.99 M USD11.6 M USD11.05 M USD9.93 M USD13.73 M USD15.02 M USD
Blood Pressure Monitoring and Accessories7.31 M USD6.51 M USD5.26 M USD4.04 M USD3.32 M USD2.83 M USD
Neonatal1.68 M USD1.52 M USD1.35 M USD1.49 M USD1.41 M USD2.25 M USD
Obstetrics1.04 M USD676,000 USD735,000 USD846,000 USD947,000 USD698,000 USD

Utah Medical Products Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Utah Medical Products Revenue by Segment

DateGlobalOUS
202350.22 M USD22.02 M USD
202252.28 M USD20.31 M USD
202149.05 M USD18.4 M USD
202042.18 M USD16.31 M USD
201946.9 M USD19.41 M USD
201842 M USD20.81 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Utah Medical Products Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Utah Medical Products historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Utah Medical Products shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Utah Medical Products earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Utah Medical Products's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Utah Medical Products’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Utah Medical Products's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Utah Medical Products stock splits

In Utah Medical Products's history, there have been no stock splits.

Utah Medical Products dividend payout ratio

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Utah Medical Products represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Utah Medical Products could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Utah Medical Products's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Utah Medical Products Payout Ratio History

DateUtah Medical Products Payout ratio
202344.9 %
202225.77 %
202170.67 %
202038.27 %
201928.12 %
201821.96 %
201746.92 %
201632.45 %
201532.64 %
201433.39 %
201332.62 %
201235.22 %
201146.55 %
2010100.91 %
200953.78 %
200848.66 %
200744.7 %
200638.61 %
200535 %
200420.55 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Utah Medical Products.

Utah Medical Products latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240 1.09  (0 %)2024 Q1
6/30/20230 1.15  (0 %)2023 Q2
12/31/20220 1.25  (0 %)2022 Q4
3/31/20140.81 0.72  (-10.65 %)2014 Q1
12/31/20130.65 0.92  (40.93 %)2013 Q4
9/30/20130.7 0.68  (-3.38 %)2013 Q3
6/30/20130.63 0.7  (10.69 %)2013 Q2
3/31/20130.71 0.73  (1.96 %)2013 Q1
12/31/19990.17 0.22  (26.87 %)1999 Q4
9/30/19990.17 0.22  (26.87 %)1999 Q3
1
2
3

Eulerpool ESG Scorecard© for the Utah Medical Products stock

Eulerpool World ESG Rating (EESG©)

66/ 100

🌱 Environment

73

👫 Social

57

🏛️ Governance

66

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Utah Medical Products shareholders

%
Name
Stocks
Change
Date
12.00065 % Fidelity Management & Research Company LLC406,82221,4176/30/2024
6.69953 % Renaissance Technologies LLC227,114-5,4006/30/2024
5.55965 % Cornwell (Kevin L)188,47203/1/2024
5.26770 % The Vanguard Group, Inc.178,575-4,5666/30/2024
5.06855 % BlackRock Institutional Trust Company, N.A.171,824-10,2806/30/2024
5.02389 % Dimensional Fund Advisors, L.P.170,3108,7006/30/2024
3.43729 % Brandes Investment Partners, L.P.116,52446,4276/30/2024
2.61251 % Geode Capital Management, L.L.C.88,56414,8856/30/2024
2.50012 % Ranger Investment Management, L.P.84,7544,3056/30/2024
2.45835 % Rice Hall James & Associates, LLC83,33816,2979/30/2024
1
2
3
4
5
...
10

Utah Medical Products Executives and Management Board

Mr. Kevin Cornwell

(76)
Utah Medical Products Chairman of the Board, President, Chief Executive Officer, Secretary (since 1992)
Compensation 451,970

Mr. Brian Koopman

Utah Medical Products Principal Financial Officer
Compensation 166,399

Mr. Ernst Hoyer

(85)
Utah Medical Products Lead Independent Director
Compensation 36,000

Dr. James Beeson

(81)
Utah Medical Products Independent Director
Compensation 28,000

Dr. Barbara Payne

(76)
Utah Medical Products Independent Director
Compensation 28,000
1
2

Most common questions regarding Utah Medical Products

What values and corporate philosophy does Utah Medical Products represent?

Utah Medical Products Inc represents the values of innovation, excellence, integrity, and customer focus. With its corporate philosophy centered around improving patient outcomes and enhancing healthcare practices, the company strives to develop and deliver high-quality medical devices and solutions to meet the evolving needs of healthcare professionals. Utah Medical Products Inc aims to foster a culture of ethical business practices, transparency, and accountability, ensuring the highest standards of quality and safety. By consistently prioritizing customer satisfaction and advancing medical technologies, Utah Medical Products Inc stands as a trusted leader in the healthcare industry.

In which countries and regions is Utah Medical Products primarily present?

Utah Medical Products Inc is primarily present in the United States.

What significant milestones has the company Utah Medical Products achieved?

Utah Medical Products Inc has achieved significant milestones over the years. In 1978, the company was incorporated and began its journey towards success. In 1987, Utah Medical launched the first specialized blood pressure monitoring system for neonates. It further expanded its product portfolio with the introduction of fetal monitoring systems in 1990. In the same year, the company went public, marking a crucial milestone in its growth. Utah Medical Products Inc continued to innovate and received FDA approval for its patented filshie clip system in 1996. These achievements highlight the company's commitment to providing advanced medical solutions and its notable contributions to the healthcare industry.

What is the history and background of the company Utah Medical Products?

Utah Medical Products Inc. is a renowned medical device company that specializes in the manufacturing and distribution of disposable and reusable medical devices for healthcare professionals and institutions. Founded in 1978, the company has established a strong presence in the healthcare industry over the years. Utah Medical Products Inc. focuses on developing innovative and safe medical devices, particularly in the areas of gynecology, neonatology, and critical care. With a commitment to quality and customer satisfaction, Utah Medical Products Inc. has become a trusted name in the healthcare sector, providing reliable and effective solutions for a variety of medical procedures and applications.

Who are the main competitors of Utah Medical Products in the market?

The main competitors of Utah Medical Products Inc in the market are XYZ Company and ABC Corporation. Both XYZ Company and ABC Corporation operate in the same industry as Utah Medical Products Inc and provide similar products and services. However, Utah Medical Products Inc distinguishes itself through its innovative medical device solutions and exceptional customer service. With its strong market position and high-quality offerings, Utah Medical Products Inc continues to excel amidst competition, delivering valuable solutions to its customers in the healthcare industry.

In which industries is Utah Medical Products primarily active?

Utah Medical Products Inc is primarily active in the medical device industry.

What is the business model of Utah Medical Products?

The business model of Utah Medical Products Inc. revolves around the development, manufacturing, and distribution of medical devices used in the healthcare industry. The company specializes in products related to the fields of obstetrics, gynecology, and neonatology. Utah Medical Products Inc. focuses on creating innovative solutions that enhance patient care and improve clinical outcomes. With a strong emphasis on research and development, the company continuously strives to introduce advanced technologies and medical devices that meet the evolving needs of healthcare professionals. Utah Medical Products Inc. aims to provide high-quality products that contribute to the overall well-being of patients and healthcare providers alike.

What is the P/E ratio of Utah Medical Products 2025?

The P/E ratio cannot be calculated for Utah Medical Products at the moment.

What is the P/S ratio of Utah Medical Products 2025?

The P/S cannot be calculated for Utah Medical Products currently.

What is the Quality Investing of Utah Medical Products?

The Quality Investing for Utah Medical Products is 6/10.

What is the revenue of Utah Medical Products 2025?

The revenue cannot currently be calculated for Utah Medical Products.

How high is the profit of Utah Medical Products 2025?

The profit cannot currently be calculated for Utah Medical Products.

What is the business model of Utah Medical Products

Utah Medical Products, Inc. is an American company specializing in the production and sale of medical devices and accessories. The company was founded in 1978 and is headquartered in Salt Lake City, Utah. Its business model focuses on various sectors, including gynecology/obstetrics, neonatology, and urology. The company offers a wide range of products in these areas to improve patient healthcare. One of its key products is the Femcare IUP (Intra-Uterine Pessary), a contraceptive device used by women, available in two different versions: the Copper T 380A and Copper T 200. Utah Medical Products also offers other products for gynecology and obstetrics, such as the EVA bleeding management system used for controlling heavy spotting and bleeding disorders. In the neonatology sector, the company provides various products specifically designed for the care of premature infants and newborns. These products include Neomentum indicators used for monitoring the breathing and heart rate of premature infants, as well as different types of umbilical cord clamps and cutters. In the urology sector, Utah Medical Products offers condom catheters used for urine diversion in men. The company also provides various types of connection tubes and drainage systems to assist in the monitoring and treatment of urinary tract infections. Its business model is closely linked to clinical research and development. The company is committed to developing innovative products and technologies that meet the needs of physicians and patients. Through close collaboration with medical professionals and research institutions, Utah Medical Products ensures that its products adhere to the highest standards of safety, efficacy, and quality. In summary, Utah Medical Products' business model aims to manufacture innovative medical devices and accessories that contribute to improving healthcare. The company focuses on multiple sectors and offers a wide range of products ranging from gynecology and obstetrics to neonatology and urology. By closely collaborating with medical professionals and continuously engaging in research and development, Utah Medical Products holds a position as a leading company in the industry.

What is the Utah Medical Products dividend?

Utah Medical Products pays a dividend of 1.17 USD distributed over payouts per year.

How often does Utah Medical Products pay dividends?

The dividend cannot currently be calculated for Utah Medical Products or the company does not pay out a dividend.

What is the Utah Medical Products ISIN?

The ISIN of Utah Medical Products is US9174881089.

What is the Utah Medical Products WKN?

The WKN of Utah Medical Products is 882656.

What is the Utah Medical Products ticker?

The ticker of Utah Medical Products is UTMD.

How much dividend does Utah Medical Products pay?

Over the past 12 months, Utah Medical Products paid a dividend of 1.19 USD . This corresponds to a dividend yield of about 1.95 %. For the coming 12 months, Utah Medical Products is expected to pay a dividend of 1.19 USD.

What is the dividend yield of Utah Medical Products?

The current dividend yield of Utah Medical Products is 1.95 %.

When does Utah Medical Products pay dividends?

Utah Medical Products pays a quarterly dividend. This is distributed in the months of April, July, October, January.

How secure is the dividend of Utah Medical Products?

Utah Medical Products paid dividends every year for the past 20 years.

What is the dividend of Utah Medical Products?

For the upcoming 12 months, dividends amounting to 1.19 USD are expected. This corresponds to a dividend yield of 1.95 %.

In which sector is Utah Medical Products located?

Utah Medical Products is assigned to the 'Health' sector.

Wann musste ich die Aktien von Utah Medical Products kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Utah Medical Products from 1/3/2025 amounting to 0.305 USD, you needed to have the stock in your portfolio before the ex-date on 12/16/2024.

When did Utah Medical Products pay the last dividend?

The last dividend was paid out on 1/3/2025.

What was the dividend of Utah Medical Products in the year 2024?

In the year 2024, Utah Medical Products distributed 1.165 USD as dividends.

In which currency does Utah Medical Products pay out the dividend?

The dividends of Utah Medical Products are distributed in USD.

All fundamentals about Utah Medical Products

Our stock analysis for Utah Medical Products Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Utah Medical Products Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.